モダリスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/10/27 | 1,101 | 1,106 | 1,051 | 1,072 | -36 | -3.2% | 114,100 |
2021/10/26 | 1,099 | 1,119 | 1,075 | 1,108 | +36 | +3.4% | 156,700 |
2021/10/25 | 1,090 | 1,090 | 1,041 | 1,072 | -23 | -2.1% | 213,400 |
2021/10/22 | 1,130 | 1,145 | 1,090 | 1,095 | -21 | -1.9% | 206,900 |
2021/10/21 | 1,160 | 1,173 | 1,116 | 1,116 | -104 | -8.5% | 486,600 |
2021/10/20 | 1,215 | 1,235 | 1,208 | 1,220 | +1 | +0.1% | 204,800 |
2021/10/19 | 1,186 | 1,230 | 1,186 | 1,219 | +19 | +1.6% | 163,400 |
2021/10/18 | 1,232 | 1,234 | 1,186 | 1,200 | -13 | -1.1% | 223,100 |
2021/10/15 | 1,198 | 1,224 | 1,183 | 1,213 | +41 | +3.5% | 198,800 |
2021/10/14 | 1,196 | 1,204 | 1,155 | 1,172 | -1 | -0.1% | 172,800 |
2021/10/13 | 1,163 | 1,197 | 1,140 | 1,173 | ±0 | ±0% | 213,600 |
2021/10/12 | 1,200 | 1,209 | 1,164 | 1,173 | -38 | -3.1% | 196,700 |
2021/10/11 | 1,237 | 1,237 | 1,191 | 1,211 | -21 | -1.7% | 180,500 |
2021/10/08 | 1,230 | 1,255 | 1,218 | 1,232 | +2 | +0.2% | 202,500 |
2021/10/07 | 1,274 | 1,280 | 1,218 | 1,230 | -37 | -2.9% | 189,600 |
2021/10/06 | 1,296 | 1,305 | 1,227 | 1,267 | +25 | +2% | 302,000 |
2021/10/05 | 1,298 | 1,300 | 1,225 | 1,242 | -71 | -5.4% | 352,700 |
2021/10/04 | 1,378 | 1,378 | 1,305 | 1,313 | -65 | -4.7% | 243,200 |
2021/10/01 | 1,359 | 1,397 | 1,350 | 1,378 | +29 | +2.1% | 166,700 |
2021/09/30 | 1,380 | 1,385 | 1,314 | 1,349 | -33 | -2.4% | 221,600 |
2021/09/29 | 1,352 | 1,401 | 1,317 | 1,382 | +20 | +1.5% | 153,300 |
2021/09/28 | 1,382 | 1,393 | 1,352 | 1,362 | -38 | -2.7% | 180,200 |
2021/09/27 | 1,413 | 1,438 | 1,388 | 1,400 | -36 | -2.5% | 157,500 |
2021/09/24 | 1,450 | 1,461 | 1,424 | 1,436 | +24 | +1.7% | 151,000 |
2021/09/22 | 1,480 | 1,510 | 1,401 | 1,412 | -69 | -4.7% | 161,200 |
2021/09/21 | 1,452 | 1,490 | 1,426 | 1,481 | -39 | -2.6% | 114,700 |
2021/09/17 | 1,491 | 1,523 | 1,460 | 1,520 | +73 | +5% | 147,700 |
2021/09/16 | 1,552 | 1,560 | 1,422 | 1,447 | -110 | -7.1% | 273,500 |
2021/09/15 | 1,580 | 1,609 | 1,549 | 1,557 | -32 | -2% | 91,600 |
2021/09/14 | 1,647 | 1,660 | 1,579 | 1,589 | -67 | -4% | 146,000 |
2021/09/13 | 1,645 | 1,667 | 1,623 | 1,656 | +8 | +0.5% | 113,500 |
2021/09/10 | 1,590 | 1,659 | 1,571 | 1,648 | +77 | +4.9% | 178,400 |
2021/09/09 | 1,598 | 1,609 | 1,553 | 1,571 | -27 | -1.7% | 176,200 |
2021/09/08 | 1,560 | 1,608 | 1,534 | 1,598 | +19 | +1.2% | 121,900 |
2021/09/07 | 1,552 | 1,583 | 1,540 | 1,579 | +47 | +3.1% | 113,100 |
2021/09/06 | 1,505 | 1,548 | 1,505 | 1,532 | +40 | +2.7% | 101,200 |
2021/09/03 | 1,481 | 1,506 | 1,454 | 1,492 | +11 | +0.7% | 156,000 |
2021/09/02 | 1,549 | 1,551 | 1,474 | 1,481 | -71 | -4.6% | 260,600 |
2021/09/01 | 1,491 | 1,580 | 1,467 | 1,552 | +77 | +5.2% | 256,100 |
2021/08/31 | 1,462 | 1,482 | 1,449 | 1,475 | +13 | +0.9% | 109,900 |
2021/08/30 | 1,457 | 1,484 | 1,434 | 1,462 | +58 | +4.1% | 179,600 |
2021/08/27 | 1,410 | 1,440 | 1,390 | 1,404 | -13 | -0.9% | 91,600 |
2021/08/26 | 1,385 | 1,429 | 1,381 | 1,417 | +32 | +2.3% | 78,300 |
2021/08/25 | 1,408 | 1,418 | 1,370 | 1,385 | -23 | -1.6% | 88,200 |
2021/08/24 | 1,384 | 1,425 | 1,364 | 1,408 | +62 | +4.6% | 228,900 |
2021/08/23 | 1,349 | 1,371 | 1,331 | 1,346 | +26 | +2% | 144,900 |
2021/08/20 | 1,323 | 1,353 | 1,312 | 1,320 | -17 | -1.3% | 101,800 |
2021/08/19 | 1,320 | 1,378 | 1,320 | 1,337 | +17 | +1.3% | 225,100 |
2021/08/18 | 1,324 | 1,359 | 1,286 | 1,320 | +19 | +1.5% | 308,300 |
2021/08/17 | 1,320 | 1,332 | 1,275 | 1,301 | -27 | -2% | 193,000 |
951~
1000
件表示中 / 1254件
類似銘柄と比較する
現在ご覧いただいている「モダリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
モダリス | 8,000円 | - | - | 0.00% | - | 1.95倍 |
|
遺伝子治療薬の創薬ベンチャー、DNA切断しないエピゲノム編集に強み。研究開発中心は米国 |
日ケミファ | 157,500円 | +7.5% | -77.4% | 3.17% | 37.88倍 | 0.30倍 |
|
後発薬中堅、検査薬事業が第2の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
PRISMBio | 17,100円 | +14.8% | - | 0.00% | - | 2.06倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
DELTA-P | 52,900円 | - | - | 0.00% | - | 22.17倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
カイノス | 127,500円 | +3.7% | +2.7% | 2.51% | 8.96倍 | 0.79倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
市場注目の銘柄
チャート関連のコラム